Clinical Trial Update: Effect of Sitagliptin on Graft Function Following Islet Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sitagliptin for graft function after islet transplantation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)

Snippet

Sponsor: University of British Columbia | Conditions: Islet Transplantation | Phase 3 | Status: TERMINATED